Walport MJ: Complement. First of two parts. N Engl J Med. 2001, 344: 1058-1066. 10.1056/NEJM200104053441406.
Article
CAS
PubMed
Google Scholar
Trouw LA, Blom AM, Gasque P: Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol. 2008, 45: 1199-1207. 10.1016/j.molimm.2007.09.008.
Article
CAS
PubMed
Google Scholar
Ricklin D, Hajishengallis G, Yang K, Lambris JD: Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010, 11: 785-797. 10.1038/ni.1923.
Article
PubMed Central
CAS
PubMed
Google Scholar
Blom AM, Villoutreix BO, Dahlbäck B: Complement inhibitor C4b-binding protein - friend or foe in the innate immune system?. Mol Immunol. 2004, 40: 1333-1346. 10.1016/j.molimm.2003.12.002.
Article
CAS
PubMed
Google Scholar
Ferreira VP, Pangburn MK, Cortes C: Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol. 2010, 47: 2187-2197. 10.1016/j.molimm.2010.05.007.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gigli I, Fujita T, Nussenzweig V: Modulation of the classical pathway C3 convertase by plasma protein C4b binding and C3b inactivator. Proc Natl Acad Sci USA. 1979, 76: 6596-6600. 10.1073/pnas.76.12.6596.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM: Complement factor I in health and disease. Mol Immunol. 2011, 48: 1611-1620. 10.1016/j.molimm.2011.04.004.
Article
CAS
PubMed
Google Scholar
Sjöberg A, Trouw LA, Blom AM: Complement activation and inhibition - a delicate balance. Trends Immunol. 2008, 30: 83-90.
Article
Google Scholar
Okroj M, Heinegård D, Holmdahl R, Blom AM: Rheumatoid arthritis and the complement system. Ann Med. 2007, 2: 1-14.
Google Scholar
Petry F: Molecular basis of hereditary C1q deficiency. Immunobiology. 1998, 199: 286-294. 10.1016/S0171-2985(98)80033-8.
Article
CAS
PubMed
Google Scholar
Sturfelt G, Sjoholm AG: Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Arch Allergy Appl Immunol. 1984, 75: 75-83. 10.1159/000233593.
Article
CAS
PubMed
Google Scholar
Walport MJ: Complement and systemic lupus erythematosus. Arthritis Res. 2002, 4 (Suppl 3): S279-293. 10.1186/ar586.
Article
PubMed Central
PubMed
Google Scholar
Cavazzana I, Manuela N, Irene C, Barbara A, Sara S, Orietta BM, Angela T, Francesco T, Luigi MP: Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?. J Autoimmun. 2007, 28: 160-164. 10.1016/j.jaut.2007.02.013.
Article
PubMed
Google Scholar
Roumenina LT, Loirat C, Dragon-Durey MA, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V: Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods. 2011, 365: 8-26. 10.1016/j.jim.2010.12.020.
Article
CAS
PubMed
Google Scholar
Trouw LA, Roos A, Daha MR: Autoantibodies to complement components. Mol Immunol. 2001, 38: 199-206. 10.1016/S0161-5890(01)00043-8.
Article
CAS
PubMed
Google Scholar
Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V: Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005, 16: 555-563. 10.1681/ASN.2004050380.
Article
CAS
PubMed
Google Scholar
Jozsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF: Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood. 2007, 110: 1516-1518. 10.1182/blood-2007-02-071472.
Article
CAS
PubMed
Google Scholar
Jozsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C: Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood. 2008, 111: 1512-1514.
Article
CAS
PubMed
Google Scholar
Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ: Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010, 115: 379-387. 10.1182/blood-2009-05-221549.
Article
PubMed Central
CAS
PubMed
Google Scholar
Strobel S, Hoyer PF, Mache CJ, Sulyok E, Liu WS, Richter H, Oppermann M, Zipfel PF, Jozsi M: Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome. Nephrol Dial Transplant. 2010, 25: 136-144. 10.1093/ndt/gfp388.
Article
CAS
PubMed
Google Scholar
Zipfel PF, Skerka C: Complement factor H and related proteins: an expanding family of complement-regulatory proteins?. Immunol Today. 1994, 15: 121-126. 10.1016/0167-5699(94)90155-4.
Article
CAS
PubMed
Google Scholar
Zipfel PF, Edey M, Heinen S, Jozsi M, Richter H, Misselwitz J, Hoppe B, Routledge D, Strain L, Hughes AE, Goodship JA, Licht C, Goodship TH, Skerka C: Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007, 3: e41-10.1371/journal.pgen.0030041.
Article
PubMed Central
PubMed
Google Scholar
Zipfel PF, Mache C, Muller D, Licht C, Wigger M, Skerka C: DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol. 2010, 25: 2009-2019. 10.1007/s00467-010-1446-9.
Article
PubMed
Google Scholar
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.
Article
CAS
PubMed
Google Scholar
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002/art.1780251101.
Article
CAS
PubMed
Google Scholar
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640. 10.1002/art.1780350606.
Article
CAS
PubMed
Google Scholar
Thiagarajan P, Pengo V, Shapiro SS: The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood. 1986, 68: 869-874.
CAS
PubMed
Google Scholar
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, PG DEG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4: 295-306. 10.1111/j.1538-7836.2006.01753.x.
Article
CAS
PubMed
Google Scholar
Blom AM, Kask L, Dahlbäck B: CCP1-4 of the C4b-binding protein a-chain are required for Factor I mediated cleavage of C3b. Mol Immunol. 2003, 39: 547-556. 10.1016/S0161-5890(02)00213-4.
Article
CAS
PubMed
Google Scholar
Blom AM, Kask L, Dahlbäck B: Structural requirements for the complement regulatory activities of C4BP. J Biol Chem. 2001, 276: 27136-27144. 10.1074/jbc.M102445200.
Article
CAS
PubMed
Google Scholar
Nilsson SC, Trouw LA, Renault N, Miteva MA, Genel F, Zelazko M, Marquart H, Muller K, Sjoholm AG, Truedsson L, Villoutreix BO, Blom AM: Genetic, molecular and functional analyses of complement factor I deficiency. Eur J Immunol. 2009, 39: 310-323. 10.1002/eji.200838702.
Article
CAS
PubMed
Google Scholar
Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, Andre JL, Takagi N, Cheong HI, Hari P, Le Quintrec M, Niaudet P, Loirat C, Fridman WH, Fremeaux-Bacchi V: Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. JASN. 2010, 21: 2180-2187. 10.1681/ASN.2010030315.
Article
PubMed Central
PubMed
Google Scholar
Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM: A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol. 2007, 44: 1845-1854. 10.1016/j.molimm.2006.10.018.
Article
Google Scholar
Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Fremeaux-Bacchi V: The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet. 2009, 46: 447-450. 10.1136/jmg.2008.064766.
Article
CAS
PubMed
Google Scholar
Sjoberg A, Önnerfjord P, Morgelin M, Heinegård D, Blom AM: The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005, 280: 32301-32308. 10.1074/jbc.M504828200.
Article
PubMed
Google Scholar
Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom AM: Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum. 2010, 62: 3574-3583. 10.1002/art.27720.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sjöberg A, Manderson GA, Mörgelin M, Day AJ, Heinegård D, Blom AM: Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2008, 46: 830-839.
Article
PubMed Central
PubMed
Google Scholar
Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Adler A, Glenn SB, Alarcon-Riquelme ME, Pons-Estel BA, Harley JB, Bae SC, Bang SY, Cho SK, Jacob CO, Vyse TJ, Niewold TB, Gaffney PM, Moser KL, Kimberly RP, Edberg JC, Brown EE, Alarcon GS, Petri MA, et al: Association of genetic variants in complement factor h and factor h-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011, 7: e1002079-10.1371/journal.pgen.1002079.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jonsen A, Nilsson SC, Ahlqvist E, Svenungsson E, Gunnarsson I, Eriksson KG, Bengtsson A, Zickert A, Eloranta ML, Truedsson L, Ronnblom L, Nordmark G, Sturfelt G, Blom AM: Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther. 2011, 13: R206-10.1186/ar3539.
Article
PubMed Central
PubMed
Google Scholar
Trouw LA, Bohringer S, Daha NA, Stahl EA, Raychaudhuri S, Kurreeman FA, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, Huizinga TW, Toes RE: The major risk alleles of age-related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA). Clin Exp Immunol. 2011, 166: 333-337. 10.1111/j.1365-2249.2011.04482.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Abarrategui-Garrido C, Martinez-Barricarte R, Lopez-Trascasa M, de Cordoba SR, Sanchez-Corral P: Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. 2009, 114: 4261-4271. 10.1182/blood-2009-05-223834.
Article
CAS
PubMed
Google Scholar